SIRT1 and Parkinson disease: The previous study showed that inhibition of Sirt1 reduced deacetylation and promoted acetylation of p53, leading to apoptosis in rodent models of systemic inflammation, Parkinson's disease, or aging-related muscular atrophy [48].